Wells Fargo
SNNA

Wells Fargo’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Wells Fargo’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-746
Closed -$1K – 7030
2019
Q2 		$1K Sell
746
-7,780
-91% -$12.2K ﹤0.01% 6327
2019
Q1 		$20K Sell
8,526
-22
-0.3% -$60 ﹤0.01% 5536
2018
Q4 		$20K Sell
8,548
-56
-0.7% -$494 ﹤0.01% 5785
2018
Q3 		$128K Buy
8,604
+463
+6% +$7.36K ﹤0.01% 5240
2018
Q2 		$124K Sell
8,141
-497
-6% -$8.44K ﹤0.01% 5282
2018
Q1 		$162K Buy
8,638
+4,203
+95% +$73.5K ﹤0.01% 5086
2017
Q4 		$80K Buy
4,435
+4,084
+1,164% +$86.4K ﹤0.01% 5395
2017
Q3 		$8K Buy
+351
New +$7.7K ﹤0.01% 5937

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return